An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where communities with numerous of members share comparison images, injection guides and assertions of rapid British shipping. Vendors market the drug there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could result in individuals administering products of unknown origin.
Some experts stated the demand for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, risking penalties, legal action or imprisonment.
Platform Reaction and Content Elimination
According to the social media company, the service has taken down problematic content and prohibited associated hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Trading Activities
Investigations also discovered groups with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of slimming results, positive reviews and detailed guides for mixing or injecting at home.
Within moments of entering one community, a seller shared contact information, where the majority of transactions take place. The seller provided an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.
Item Information and Pricing
Within these communities, posts show black plastic parcels with postal service labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how much time a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service said it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.
Her team has previously seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to possibly significant medical dangers”.
